4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-20-000005
CEO bought 400 shares at an average $0.10 ($41)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Collier Alan Brian CEO | 2020-06-30 | Purchase | +200 | $0.10 | $21 | 26,019 | D: show line 1 in the form |
| Collier Alan Brian CEO | 2020-07-01 | Purchase | +100 | $0.10 | $10 | 26,119 | D: show line 2 in the form |
| Collier Alan Brian CEO | 2020-07-01 | Purchase | +100 | $0.10 | $10 | 26,219 | D: show line 3 in the form |
| Open-market purchases · 400 sh · avg $0.10 · $41 | |||||||
Loading xslF345X03/primary_doc.xml…